Alert to physicians: possible interaction of aggrenox and adenosine.
Bergmann
S R
SR
D000241:Adenosine / Q000627:therapeutic use*; D001241:Aspirin; D000068342:Aspirin, Dipyridamole Drug Combination; D002545:Brain Ischemia / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000068342:Aspirin, Dipyridamole Drug Combination; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D004176:Dipyridamole; D000241:Adenosine; D001241:Aspirin